beta
IMMY
Imprimis Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Imprimis Pharmaceuticals Inc is engaged in the development, production and sale of medications that offer competitive advantages and serve unmet needs. The Company intends to deliver high-quality medications to physicians and patients.
Market Cap: 32.2 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.imprimispharma.com
Shares Outstanding: 20.5 Million
Float: 16.2 Million
Dividend: 0.0 (0.0%)
Beta: -0.411755
Sector: Healthcare
Industry: Drug Manufacturers
Ethical Flags
Longest drawdown: 1478 trading days
From: 2013-05-31 To: 2018-12-31
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2013-02-08 | 5.0 | 1.0 | 5.0 |